Just an fyi on mnkd, the product that just won the adcom support yesterday is really not just a product but a platform. They are already working on the next venture for the inhaler device which is called dreamboat, that is for pain? Inhaled pain meds. Where ever you need rapid acting meds you can use this device. They also have 10B dollars in product already paid for and 2.5B in development costs to write off. Once they start producing and selling, this is a rocket. Do not sell mnkd or at least trade around a position. Partner and approval are up next. Keep in mind the shorts are relentless. Adam Furstein actually changed sides yesterday.
News 
Market Data 
Discover 
AI
